An impact of basis therapy on quality of life in bronchial asthma children

Abstract

The object of the investigation was to define a dynamics of quality of life and to evaluate an influence of different pharm acotherapeutic methods on bronchial asthma child's w ell-being. The analysis of quality of life was carried out in 264 bronchial asthma (BA) children of 4 -1 6 years old and 55 healthy children of the same age in Vladivostok Childhood Asthma Centre in 19 98 -199 9 using the Russian version of A. West's and D .French's "Childhood asthma questionnaire" adopted by V.I.Petrov and I.V.Smolenov. The BA patients were determined to have life activity reduced in combination with deep distress that led to child's misadaptation among the same aged children. The dynamics of quality of life in moderate bronchial asthma patients showed the positive influence of the basic therapy on their well-being. It was m ore distinct when using sodium nedocromil (Tilade) and fluticazone propionate (Flixotide). The analysis contributed to the clinical assessment of the therapy efficacy and proved that capacity of correction of the BA child’s life activity and its period are mostly determined by a medication choice.